Dicloxacillin Sodium hydrate

• CAT Number: I001305
• CAS Number: 13412-64-1
• Molecular Formula: C19H18Cl2N3NaO6S
• Molecular Weight: 510.32
• Purity: ≥95%
• Solubility: H2O: ≥ 32 mg/mL
• Storage: Store at -20°C
• IUPAC Name: sodium;(2S,5R,6R)-6-[[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate;hydrate
• InChI: InChI=1S/C19H17Cl2N3O5S.Na.H2O/c1-7-10(12(23-29-7)11-8(20)5-4-6-9(11)21)15(25)22-13-16(26)24-14(18(27)28)19(2,3)30-17(13)24;;/h4-6,13-14,17H,1-3H3,(H,22,25)(H,27,28);;1H2/q;+1;/p-1/t13-,14+,17-;;/m1../s1
• InChIKey: SIGZQNJITOWQEF-VICXVTCVSA-M
• SMILES: CC1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)[O-].O.[Na+]

Dicloxacillin Sodium Hydrate（Cat No.:I001305）is a semisynthetic penicillin antibiotic used primarily for treating bacterial infections, particularly those caused by penicillinase-producing staphylococci. This compound works by inhibiting the synthesis of bacterial cell walls, preventing bacterial growth and proliferation. Dicloxacillin is effective against a wide range of Gram-positive bacteria, including Staphylococcus aureus and Streptococcus pneumoniae. It is commonly prescribed for skin infections, respiratory tract infections, and bone and joint infections. The sodium hydrate form ensures better solubility and bioavailability, making it suitable for intravenous or oral administration in clinical settings.